U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Breast neoplasm

MedGen UID:
264172
•Concept ID:
C1458155
•
Neoplastic Process
Synonyms: Breast Neoplasms; Breast tumor; Neoplasm of breast; Neoplasm of the breast
SNOMED CT: Neoplasm of breast (126926005); Breast tumor (126926005); Tumor of breast (126926005)
 
Related genes: BRIP1, PALB2, CHEK2, RB1CC1, PPM1D, RAD54L, XRCC3, TP53, STK11, RAD51D, RAD51C, RAD51, PTEN, PIK3CA, PHB1, SLC22A18, NQO2, KRAS, HMMR, ESR1, CDH1, CASP8, BRCA2, BRCA1, BARD1, ATM, AKT1
 
HPO: HP:0100013
Monarch Initiative: MONDO:0021100

Definition

A tumor (abnormal growth of tissue) of the breast. [from HPO]

Term Hierarchy

Professional guidelines

PubMed

Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan.
Bardia A, Harnden K, Mauro L, Pennisi A, Armitage M, Soliman H
Oncologist 2022 Aug 5;27(8):637-645. doi: 10.1093/oncolo/oyac107. PMID: 35642907Free PMC Article
Body composition and breast cancer risk and treatment: mechanisms and impact.
Iwase T, Wang X, Shrimanker TV, Kolonin MG, Ueno NT
Breast Cancer Res Treat 2021 Apr;186(2):273-283. Epub 2021 Jan 21 doi: 10.1007/s10549-020-06092-5. PMID: 33475878
A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews.
Olsson Möller U, Beck I, Rydén L, Malmström M
BMC Cancer 2019 May 20;19(1):472. doi: 10.1186/s12885-019-5648-7. PMID: 31109309Free PMC Article

Curated

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML
J Natl Compr Canc Netw 2011 Nov;9 Suppl 5:S1-32; quiz S33. doi: 10.6004/jnccn.2011.0137. PMID: 22138009

Breast Cancer, NCCN Guidelines Version 4.2022

Breast Cancer Screening and Diagnosis, NCCN, Version 1.2022

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer, NICE, 2018

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast Cancer (See 2022 Update)

DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: information for the public

Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)

Suggested Reading

PubMed

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators
N Engl J Med 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253. PMID: 27557300
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.
Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P, Wyld L
Health Technol Assess 2013 Oct;17(44):1-302. doi: 10.3310/hta17440. PMID: 24088296Free PMC Article

Recent clinical studies

Etiology

Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review.
Ficarra S, Thomas E, Bianco A, Gentile A, Thaller P, Grassadonio F, Papakonstantinou S, Schulz T, Olson N, Martin A, Wagner C, Nordström A, Hofmann H
Breast Cancer 2022 May;29(3):402-418. Epub 2022 Mar 12 doi: 10.1007/s12282-022-01347-z. PMID: 35278203Free PMC Article
Menopausal hormone therapy and breast cancer risk.
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C
Best Pract Res Clin Endocrinol Metab 2021 Dec;35(6):101577. Epub 2021 Sep 10 doi: 10.1016/j.beem.2021.101577. PMID: 34535397
Body composition and breast cancer risk and treatment: mechanisms and impact.
Iwase T, Wang X, Shrimanker TV, Kolonin MG, Ueno NT
Breast Cancer Res Treat 2021 Apr;186(2):273-283. Epub 2021 Jan 21 doi: 10.1007/s10549-020-06092-5. PMID: 33475878
Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.
Hasenoehrl T, Palma S, Ramazanova D, Kölbl H, Dorner TE, Keilani M, Crevenna R
Support Care Cancer 2020 Aug;28(8):3593-3603. Epub 2020 May 15 doi: 10.1007/s00520-020-05521-x. PMID: 32415386Free PMC Article
A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.
Youn HJ, Han W
Asian Pac J Cancer Prev 2020 Apr 1;21(4):867-880. doi: 10.31557/APJCP.2020.21.4.867. PMID: 32334446Free PMC Article

Diagnosis

The prevalence of frailty among breast cancer patients: a systematic review and meta-analysis.
Wang S, Yang T, Qiang W, Shen A, Zhao Z, Yang H, Liu X
Support Care Cancer 2022 Apr;30(4):2993-3006. Epub 2021 Oct 25 doi: 10.1007/s00520-021-06641-8. PMID: 34694496
Long-term quality of life among breast cancer survivors eligible for screening at diagnosis: a systematic review and meta-analysis.
Moshina N, Falk RS, Hofvind S
Public Health 2021 Oct;199:65-76. Epub 2021 Sep 21 doi: 10.1016/j.puhe.2021.08.008. PMID: 34560477
Breast fibroadenomas: a review in the light of current literature.
Salati SA
Pol Przegl Chir 2020 Dec 7;93(1):40-48. doi: 10.5604/01.3001.0014.5676. PMID: 33729177
A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.
Youn HJ, Han W
Asian Pac J Cancer Prev 2020 Apr 1;21(4):867-880. doi: 10.31557/APJCP.2020.21.4.867. PMID: 32334446Free PMC Article
Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer.
Reinert T, de Paula B, Shafaee MN, Souza PH, Ellis MJ, Bines J
Chin Clin Oncol 2018 Jun;7(3):25. doi: 10.21037/cco.2018.06.06. PMID: 30056727

Therapy

Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review.
Ficarra S, Thomas E, Bianco A, Gentile A, Thaller P, Grassadonio F, Papakonstantinou S, Schulz T, Olson N, Martin A, Wagner C, Nordström A, Hofmann H
Breast Cancer 2022 May;29(3):402-418. Epub 2022 Mar 12 doi: 10.1007/s12282-022-01347-z. PMID: 35278203Free PMC Article
Menopausal hormone therapy and breast cancer risk.
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C
Best Pract Res Clin Endocrinol Metab 2021 Dec;35(6):101577. Epub 2021 Sep 10 doi: 10.1016/j.beem.2021.101577. PMID: 34535397
Body composition and breast cancer risk and treatment: mechanisms and impact.
Iwase T, Wang X, Shrimanker TV, Kolonin MG, Ueno NT
Breast Cancer Res Treat 2021 Apr;186(2):273-283. Epub 2021 Jan 21 doi: 10.1007/s10549-020-06092-5. PMID: 33475878
Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.
Hasenoehrl T, Palma S, Ramazanova D, Kölbl H, Dorner TE, Keilani M, Crevenna R
Support Care Cancer 2020 Aug;28(8):3593-3603. Epub 2020 May 15 doi: 10.1007/s00520-020-05521-x. PMID: 32415386Free PMC Article
A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews.
Olsson Möller U, Beck I, Rydén L, Malmström M
BMC Cancer 2019 May 20;19(1):472. doi: 10.1186/s12885-019-5648-7. PMID: 31109309Free PMC Article

Prognosis

Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.
Chen SY, Sun GY, Tang Y, Jing H, Song YW, Jin J, Liu YP, Zhao XR, Song YC, Chen B, Qi SN, Tang Y, Lu NN, Li N, Fang H, Li YX, Wang SL
Eur J Cancer 2022 Oct;174:153-164. Epub 2022 Aug 20 doi: 10.1016/j.ejca.2022.07.023. PMID: 35998550
Hormone Resistance.
Yu J
Adv Exp Med Biol 2021;1187:391-401. doi: 10.1007/978-981-32-9620-6_20. PMID: 33983590
A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.
Youn HJ, Han W
Asian Pac J Cancer Prev 2020 Apr 1;21(4):867-880. doi: 10.31557/APJCP.2020.21.4.867. PMID: 32334446Free PMC Article
Luminal A Breast Cancer and Molecular Assays: A Review.
Gao JJ, Swain SM
Oncologist 2018 May;23(5):556-565. Epub 2018 Feb 22 doi: 10.1634/theoncologist.2017-0535. PMID: 29472313Free PMC Article
Black cohosh and breast cancer: a systematic review.
Fritz H, Seely D, McGowan J, Skidmore B, Fernandes R, Kennedy DA, Cooley K, Wong R, Sagar S, Balneaves LG, Fergusson D
Integr Cancer Ther 2014 Jan;13(1):12-29. Epub 2013 Feb 25 doi: 10.1177/1534735413477191. PMID: 23439657

Clinical prediction guides

Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review.
Ficarra S, Thomas E, Bianco A, Gentile A, Thaller P, Grassadonio F, Papakonstantinou S, Schulz T, Olson N, Martin A, Wagner C, Nordström A, Hofmann H
Breast Cancer 2022 May;29(3):402-418. Epub 2022 Mar 12 doi: 10.1007/s12282-022-01347-z. PMID: 35278203Free PMC Article
Body composition and breast cancer risk and treatment: mechanisms and impact.
Iwase T, Wang X, Shrimanker TV, Kolonin MG, Ueno NT
Breast Cancer Res Treat 2021 Apr;186(2):273-283. Epub 2021 Jan 21 doi: 10.1007/s10549-020-06092-5. PMID: 33475878
Breast fibroadenomas: a review in the light of current literature.
Salati SA
Pol Przegl Chir 2020 Dec 7;93(1):40-48. doi: 10.5604/01.3001.0014.5676. PMID: 33729177
Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.
Hasenoehrl T, Palma S, Ramazanova D, Kölbl H, Dorner TE, Keilani M, Crevenna R
Support Care Cancer 2020 Aug;28(8):3593-3603. Epub 2020 May 15 doi: 10.1007/s00520-020-05521-x. PMID: 32415386Free PMC Article
Luminal A Breast Cancer and Molecular Assays: A Review.
Gao JJ, Swain SM
Oncologist 2018 May;23(5):556-565. Epub 2018 Feb 22 doi: 10.1634/theoncologist.2017-0535. PMID: 29472313Free PMC Article

Recent systematic reviews

Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review.
Ficarra S, Thomas E, Bianco A, Gentile A, Thaller P, Grassadonio F, Papakonstantinou S, Schulz T, Olson N, Martin A, Wagner C, Nordström A, Hofmann H
Breast Cancer 2022 May;29(3):402-418. Epub 2022 Mar 12 doi: 10.1007/s12282-022-01347-z. PMID: 35278203Free PMC Article
Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.
Hasenoehrl T, Palma S, Ramazanova D, Kölbl H, Dorner TE, Keilani M, Crevenna R
Support Care Cancer 2020 Aug;28(8):3593-3603. Epub 2020 May 15 doi: 10.1007/s00520-020-05521-x. PMID: 32415386Free PMC Article
Systematic review of shift work and nurses' health.
Rosa D, Terzoni S, Dellafiore F, Destrebecq A
Occup Med (Lond) 2019 Jun 24;69(4):237-243. doi: 10.1093/occmed/kqz063. PMID: 31132107
A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews.
Olsson Möller U, Beck I, Rydén L, Malmström M
BMC Cancer 2019 May 20;19(1):472. doi: 10.1186/s12885-019-5648-7. PMID: 31109309Free PMC Article
Black cohosh and breast cancer: a systematic review.
Fritz H, Seely D, McGowan J, Skidmore B, Fernandes R, Kennedy DA, Cooley K, Wong R, Sagar S, Balneaves LG, Fergusson D
Integr Cancer Ther 2014 Jan;13(1):12-29. Epub 2013 Feb 25 doi: 10.1177/1534735413477191. PMID: 23439657

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2023
      Breast Cancer, NCCN Guidelines Version 4.2022
    • NCCN, 2022
      Breast Cancer Screening and Diagnosis, NCCN, Version 1.2022
    • NICE, 2018
      Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)
    • NICE, 2018
      Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer, NICE, 2018
    • NCCN, 2014
      National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast Cancer (See 2022 Update)
    • NICE, 2013
      DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: information for the public
    • AHRQ, 2013
      Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)
    • NCCN, 2011
      NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

    Consumer resources

    Reviews

    Related information

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...